Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Arrhythmias, Cardiac

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Arrhythmias, Cardiac in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, JL; Carlquist, JF; Fang, WB; Huntinghouse, JA; Johnson, EG; Knight, S; Moody, DE; Rollo, JS; Webster, LR1

Other Studies

1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Arrhythmias, Cardiac

ArticleYear
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.
    Molecular diagnosis & therapy, 2015, Volume: 19, Issue:2

    Topics: Adult; Alleles; Arrhythmias, Cardiac; Cytochrome P-450 CYP2C19; Electrocardiography; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methadone; Pharmacogenetics; Pilot Projects; Polymorphism, Single Nucleotide; Pyrrolidines; Time Factors; Young Adult

2015